Author’s replyA letter of response to comments on ‘A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers’
Section snippets
Conflict of interest statement
The authors declare no conflict of interest.
References (11)
- et al.
BIG-RENAPE Networks. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers
Eur J Canc
(2020) Role of leucovorin dosing and administration schedule
Eur J Canc
(1995)- et al.
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
Ann Oncol
(2002) - et al.
Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis
Surg Oncol Clin
(2003) - Rovers KP, Lurvink RJ, Deenen MJ, de Hingh IHJT. PIPAC-oxaliplatin for peritoneal metastases of gastrointestinal...
There are more references available in the full text version of this article.
Cited by (0)
© 2021 Elsevier Ltd. All rights reserved.